Testing Laboratories and Services (U.S., NAICS 54138)

A short rollup primer. This level has exactly one child industry — 541380, Testing Laboratories and Services — so the two are effectively identical. Read this page for the level's own ground-truth figures and the big picture; see the 541380 primer for the full detail on economics, regulation, the investable universe, and risks.

1. Overview

Testing laboratories are the independent referees of the physical economy. When a water utility must prove its supply is safe, a builder must certify that concrete will bear a load, a manufacturer must show a battery will not catch fire, or a pipeline operator must confirm a weld has not cracked, a third-party lab runs the measurement and issues a defensible result. The work is unglamorous, deeply embedded in law and contracts, and — because most of it is required rather than optional — remarkably steady.

The North American Industry Classification System (NAICS) is the U.S. government's standard for grouping businesses. This five-digit code, 54138 — Testing Laboratories and Services, covers establishments that perform physical, chemical, and other analytical testing as a service to others: environmental testing (soil, water, air), materials and mechanical testing, geotechnical (soil-and-foundation) testing, calibration, electrical and electronic testing, and non-destructive testing, or NDT (inspecting a part without damaging it).[4]

Why it matters to an investor: demand is largely non-discretionary and regulation-driven, the work is sticky and repeat-based, margins are healthy, and the industry is extraordinarily fragmented — a textbook setup for "buy-and-build" consolidation. Direct public-market exposure is thin and mostly foreign, while private markets host one of the most active roll-up sectors in business services.

2. What's inside — and why this level equals its one child

NAICS is a nested hierarchy: each five-digit "industry" splits into one or more six-digit "national industries." In many parts of the taxonomy a five-digit code fans out into several children. Here it does not. NAICS 54138 contains a single child, 541380, which carries exactly the same name and the same definition. The U.S. never subdivided testing laboratories any finer, so the five-digit total and the six-digit total are one and the same number — there is no aggregation across siblings, because there are no siblings.

That is why this page is short. Everything substantive about the industry — its structure, ownership mix, unit economics, demand drivers, regulatory scaffolding, consolidation dynamics, and risks — lives in the 541380 leaf primer, and repeating it here would only duplicate it. The sections below give this level's own ground-truth statistics and a compact orientation, then point you there.

3. Size (this level's rollup figures)

These are the ground-truth federal figures for NAICS 54138. Because the level has one child, they are identical to 541380's. They come from different Census programs and years and should not be treated as one perfectly synchronized market-size series.

That works out to roughly $75,000 in average annual pay per worker[1] — a skilled workforce of chemists, technicians, and engineers — across an average establishment of about 21 employees,[1] confirming these are real payroll businesses, not one-person shops.

Undercount caveat. The $27.9 billion figure is the independent commercial market only. The Economic Census generally covers establishments with paid employees and excludes government-operated businesses; County Business Patterns also excludes the self-employed and most government employees.[5] Total testing activity in the U.S. economy is far larger and split across buckets this count misses: testing performed inside manufacturers' own facilities (counted under the parent's manufacturing code), government and university labs, and large "testing, inspection and certification" (TIC) firms' revenue booked under adjacent engineering and consulting codes. Third-party market-research estimates of the broader U.S. TIC market commonly run $50–70 billion for 2024–2025, depending on how much inspection and certification each analyst folds in.[6] Treat the federal number as the reliable floor for the pure-testing core. Note also that this is genuinely an employer industry — it is not badly distorted by tiny individually owned operators the way some service codes are.

4. Investable universe (where value concentrates)

Because the level equals its one child, value concentrates exactly where it does in 541380: not in any single U.S. pure-play, but across a handful of U.S.-listed operators and a set of larger foreign-listed global majors, with the deepest opportunity in private markets. In brief:

• U.S.-listed: UL Solutions (NYSE: ULS, product-safety testing/certification), TIC Solutions (NYSE: TIC, industrial NDT and asset integrity), Mistras Group (NYSE: MG, NDT), and Montrose Environmental (NYSE: MEG, environmental labs bundled with services).[7][8][9][10]
• Foreign-listed global majors (reachable via American Depositary Receipts, or ADRs, and over-the-counter lines): SGS, Bureau Veritas, Intertek, Eurofins Scientific, and ALS Limited.[11][12][13]
• Private / private-equity-backed platforms: Element Materials Technology, Pace Analytical, Applus+, plus foundation- and association-owned groups (DNV, the TÜV bodies, DEKRA, NSF).[14][15]

None is a clean proxy for U.S. NAICS 54138 revenue — each blends testing with inspection, certification, advisory, software, or non-U.S. operations. See the child primer for the full table with scale figures and the exposure-mapping approach.

5. How the money works

A testing lab's economics look like a hybrid of a factory and a professional-services firm. Revenue is built from sample volume × price per test (bench-based analytical labs) and billable hours × utilization (field NDT and geotechnical crews). Heavy fixed costs — buildings, instruments, accreditation, quality-assurance staff — make profit highly sensitive to filling capacity, so incremental samples on already-built capacity drop a lot to the bottom line (operating leverage). Reported EBITDA (earnings before interest, taxes, depreciation, and amortization) margins run 12–20%, with the best-run global majors at 18–23%.[21] The moat is accreditation breadth, network density, scientific reputation, and switching costs from validated methods and customer-specific workflows. The federal data cover none of this — it comes from company disclosures. Full detail is in the child primer.

6. Demand drivers

The single biggest driver is regulation: environmental, food-safety, drug and device, consumer-product, workplace-safety, and building-code rules all mandate testing by accredited third parties, and demand rises with each new rule and tightened limit. The current wave is PFAS — per- and polyfluoroalkyl substances, or "forever chemicals" — where the Environmental Protection Agency has set enforceable drinking-water limits and committed roughly $1 billion in 2026 to state-led water projects, driving a PFAS-testing market growing at a mid-teens annual rate.[15][16] Other drivers: outsourcing, industrial and infrastructure capital spending (the cyclical portion), product complexity (electric-vehicle batteries, semiconductors, medical devices), pharma/biotech development, trade and supply-chain compliance, and asset-integrity/liability work. See the child primer for the full list.

7. Regulation

Regulation shapes this industry twice — as the source of demand and as the barrier to entry. The foundational lab credential is ISO/IEC 17025 (the international standard for the technical competence of testing and calibration labs), granted method-by-method and issued in the U.S. through the National Institute of Standards and Technology's NVLAP program and private bodies such as A2LA and ANAB.[17] Environmental labs additionally need NELAP (National Environmental Laboratory Accreditation Program) recognition.[15] Labs must run officially prescribed methods (EPA, ASTM, USP, AOAC), and a lab can only sell a regulated test if it is accredited for that specific method — which is what turns each accreditation into a competitive asset.[15] Product certification runs through the Occupational Safety and Health Administration's NRTL (Nationally Recognized Testing Laboratory) program.[18] The child primer covers Good Laboratory Practice, federal contracting set-asides, and the full regulatory map.

8. Consolidation

By the federal numbers this is one of the most fragmented industries you will encounter: the four largest firms hold just 15.3% of revenue, the top fifty only 49.8%, and the HHI sits at 103 — near the floor (below 1,500 is considered unconcentrated).[2] That fragmentation is exactly why the sector is a consolidation engine: global majors and private-equity platforms buy small labs to add methods, geography, and volume. Recent moves include Acuren's merger with NV5 Global to form the >$2 billion TIC Solutions (2025), SGS and Bureau Veritas's abandoned ~$33 billion merger talks (January 2025), and Applus+'s take-private.[8][19] Deal activity is heavy — well over 280 announced TIC transactions in 2025 — with public TIC companies trading around a median 14.3× EV/EBITDA (enterprise value to EBITDA).[20][21]

9. Risks

The main risks are the same as 541380's: cyclicality in the construction-materials, geotechnical, and energy-NDT segments; regulatory dependence that cuts both ways (deregulation or weaker enforcement shrinks mandated testing); labor scarcity among credentialed scientists and inspectors; commoditization of routine high-volume tests; capital intensity of new methods; quality/liability/reputation exposure, where a single failure can cost a lab its accreditation and a market; customer insourcing and concentration; and, for the acquisitive platforms, roll-up execution risk (overpaying, excessive debt, weak integration). Public-company results also bundle inspection, certification, consulting, software, and non-U.S. operations that do not map cleanly to NAICS 54138. See the child primer for the full treatment.

10. How to invest & outlook

Direct U.S.-listed exposure is limited but real (ULS, TIC, MG, MEG); the deepest pure-plays are the foreign global majors (SGS, Bureau Veritas, Eurofins, Intertek, ALS), reachable through ADRs or foreign lines.[7][8][9][10][11][12][13] There is no meaningful dedicated U.S. testing-lab exchange-traded fund (ETF), so investors get exposure through individual names or diversified business-services funds. The richest opportunity set is in private markets, where a fragmented base, sticky regulation-driven revenue, and healthy margins make independent labs prime buy-and-build targets. The outlook is constructive but selective: PFAS testing, reshoring, semiconductor and battery build-outs, and infrastructure spending support demand, while the industrial-cyclical segments stay hostage to the capex cycle and the regulated core is only as strong as the will to enforce the rules that mandate it. The bottom line: testing labs are "trust plus throughput" businesses — the moat is not owning instruments, it is producing defensible results quickly, under recognized methods, for customers that cannot afford to be wrong.

For the complete analysis — company-by-company scale figures, unit economics, the full regulatory and consolidation picture, and detailed diligence checklists — see the 541380 primer.

---

Sources

1. U.S. Census Bureau, County Business Patterns (2023), NAICS 541380 — employment, establishments, annual and first-quarter payroll. https://www.census.gov/programs-surveys/cbp.html
2. U.S. Census Bureau, 2022 Economic Census, Concentration by Largest Firms, NAICS 541380 — receipts, firm count, concentration ratios (CR4/CR8/CR20/CR50), HHI. https://data.census.gov/table/ECNSIZE2022.EC2200SIZECONCEN
3. U.S. Census Bureau / NAICS, 2022 NAICS Definition, 541380 Testing Laboratories and Services (scope and exclusions). https://www.census.gov/naics/?input=541380&year=2022
4. U.S. Census Bureau, About the 2022 Economic Census and County Business Patterns Methodology (coverage of employer establishments; exclusion of government and self-employed). https://www.census.gov/programs-surveys/economic-census/year/2022/about.html
5. MarketsandMarkets / Aventis Advisors, U.S. and Global TIC market — SGS, Bureau Veritas and Intertek combined scale and share (2025). https://aventis-advisors.com/top-10-largest-testing-inspection-and-certification-companies-globally/
6. UL Solutions Inc., Full-Year 2024 Results and Form 10-K; controlled by UL Standards & Engagement. https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001901440&type=10-K
7. Acuren Corporation, FY2024 Results and Acuren–NV5 Global Merger (2025); renamed TIC Solutions, Inc. https://www.businesswire.com/news/home/20250515498193/en/
8. Mistras Group, Inc. (NYSE: MG), 2024 revenue and profile. https://investors.mistrasgroup.com/financial-information/annual-reports
9. Montrose Environmental Group, Record Fourth Quarter and Full Year 2024 Results (Measurement & Analysis segment). https://www.prnewswire.com/news-releases/montrose-environmental-group-reports-record-fourth-quarter-and-full-year-2024-results-and-provides-strong-2025-guidance-302386522.html
10. Eurofins Scientific, Full-Year 2024 Results (North America ~38% of net sales; U.S. PFAS-testing leadership). https://www.businesswire.com/news/home/20250129893744/en/
11. SGS SA, 2024 Annual Results (sales CHF 6.794 billion). https://www.sgs.com/en/investor-relations
12. Bureau Veritas, 2024 Full-Year Results (revenue ~€6.3 billion). https://group.bureauveritas.com/investors/our-profile/key-figures
13. Temasek / Element Materials Technology, Temasek completes ~$7bn acquisition of Element (2022). https://www.element.com/about-element/news/2022/07/05/element-announces-completion-of-its-acquisition-by-temasek
14. TDR Capital / I Squared Capital, Amber EquityCo takes Applus+ private (2024). https://www.tdrcapital.com/portfolio/applus/
15. U.S. EPA, Clean Water Act and drinking-water PFAS analytical methods (533, 537.1, 1633A), drinking-water limits and 2026 funding, plus TNI/NELAP, A2LA, and DoD ELAP accreditation frameworks. https://www.epa.gov/cwa-methods/cwa-analytical-methods-and-polyfluorinated-alkyl-substances-pfas
16. MarketsandMarkets, PFAS Testing Market (~$0.49B in 2025 to ~$0.97B by 2030, ~14.5% CAGR). https://www.marketsandmarkets.com/Market-Reports/pfas-testing-market.asp
17. National Institute of Standards and Technology, About NVLAP (ISO/IEC 17025 accreditation). https://www.nist.gov/nvlap/about-nvlap
18. Occupational Safety and Health Administration, Nationally Recognized Testing Laboratory (NRTL) Program. https://www.osha.gov/nationally-recognized-testing-laboratory-program
19. SwissInfo, SGS and Bureau Veritas end ~$33bn merger talks (January 2025). https://www.swissinfo.ch/eng/business/sgs-bureau-veritas-merger-talks/
20. Consultancy.eu / Houlihan Lokey, TIC & Compliance M&A — 280+ announced transactions in 2025. https://www.consultancy.eu/news/13863/ma-in-testing-inspection-certification-and-compliance-sector-remains-upbeat
21. Aventis Advisors, TIC Company Valuations: Testing, Inspection, and Certification M&A Report (median ~14.3× EV/EBITDA; sector EBITDA margins; Eurofins/SGS/Bureau Veritas acquisition counts), 2025. https://aventis-advisors.com/tic-company-valuations/